Alvotech Financials from Morningstar (USX:ALVO)

USX:ALVO - Alvotech Alvotech
Sector: Health Care, Industry: Pharmaceuticals

Add Alert

Balance Sheet Cash Flow Income Statement Key Ratios

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1
Insider Holdings (%)	[friend]	-	-	-	-	-	-	-	-	-	-	-
Net Margin	[friend]	-	729.94% -	-17.03K% -	-270.99% -	-45.15% -	-1.34K% -	-1.74K% -	4.31K% -	-1.06K% -	-517.99% -	-593.53% -
Gross Margin	[friend]	-	100% -	-286.73% -	59.5% -	7.89% -86.7%	-20.43% -	-146.44% -	-556.21% -	-105.34% -	-5.67% -	45.85% -
Operating Margin	[friend]	-	41.81% -	-15.99K% -	-331.06% -	-325.78% -	-338.62% -	-606.87% -	-2.11K% -	-498.1% -	-144.51% -	-131.39% -
Total Revenue	[friend]	0 -100%	34.76M -	452K -98.7%	39.67M 8675.7%	19.05M -52.0%	23.86M 25.2%	15.86M -33.5%	4.39M -72.3%	17.79M 305.1%	53.39M 200.1%	36.85M -31.0%
Total Assets	[friend]	-	597.98M -	-	774.5M -	683.13M -11.8%	828.44M 21.3%	895.47M 8.1%	910.66M 1.7%	958.82M 5.3%	950.09M -0.9%	1.06B 11.6%
Total Liabilities	[friend]	-	733.59M -	-	1.07B -	960.36M -10.3%	1.39B 45.0%	1.55B 11.4%	1.39B -10.4%	1.62B 16.6%	1.88B 16.2%	1.72B -8.7%
Total Equity	[friend]	-	-135.61M -	-	-296.22M -	-277.23M -	-564.42M -	-655.77M -	-478.54M -	-660.85M -	-932.49M -	-658.83M -
Operating CashFlow	[friend]	-72.68M -	-70.76M -	-37.58M -	-103.57M -	-106.86M -	-64.38M -	-86.13M -	-41.87M -	-117.02M -	-67.16M -	-75.4M -
Beginning Cash Position	[friend]	41.99M 32.5%	3.99M -90.5%	17.56M 340.4%	21.13M 20.4%	128.44M 507.9%	12.84M -90.0%	66.43M 417.2%	115.84M 74.4%	60.47M -47.8%	68.31M 13.0%	11.16M -83.7%
End Cash Position	[friend]	3.99M -90.5%	17.56M 340.4%	21.13M 20.4%	128.44M 507.9%	12.84M -90.0%	66.43M 417.2%	115.84M 74.4%	60.47M -47.8%	68.31M 13.0%	11.16M -83.7%	64.81M 480.9%
Free Cash Flow	[friend]	-75.61M -	-101.49M -	-50.78M -	-117.35M -	-118.42M -	-74.84M -	-100.01M -	-53.35M -	-127.67M -	-77.62M -	-80.02M -
Net Income (Cont Operations)	[friend]	-81.31M -	253.76M -	-76.98M -	-107.49M -	-8.6M -	-320.51M -	-276.18M -	189.33M -	-188.32M -	-276.56M -	-218.73M -
Diluted Net Income	[friend]	-81.31M -	253.76M -	-76.98M -	-107.49M -	-8.6M -	-320.51M -	-276.18M -	189.33M -	-188.32M -	-276.56M -	-218.73M -
Diluted EPS	[friend]	-0.735 -	1.041 -	-0.316 -	-0.435 -	0.02 -	-1.6 -	-1.24 -	0.85 -	-0.82 -	-1.22 -	-0.89 -
Return On Equity (%)	[friend]	-	-	-	-	-	-	-	-	-	-	-
Return On Assets (%)	[friend]	-	42.44% -	-	-13.88% -	-1.18% -	-42.41% -	-32.04% -	20.96% -	-20.15% -	-28.98% -	-21.76% -

Values are in USD whenever applicable | Fiscal year ends on December 31

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes

Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing

Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko

Your Account
Settings
Subscriptions
Referrals
Messages
Profile

Server T4